Prothena Corporation plc (PRTA)
NASDAQ · Healthcare
Prothena Corporation plc EBITDA 2012–2025
Prothena Corporation plc annual/quarterly ebitda history and growth rate from 2012 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Prothena Corporation plc ebitda for the quarter ending March 31, 2026 was 30.2 M, a 146.24% decrease year-over-year.
- Prothena Corporation plc ebitda for the twelve months ending March 31, 2026 was -172.6 M, a 48.01% increase year-over-year.
- Prothena Corporation plc annual ebitda for 2025 was -213.7 M, a 39.10% increase from 2024.
- Prothena Corporation plc annual ebitda for 2024 was -153.7 M, a 19.17% decrease from 2023.
- Prothena Corporation plc annual ebitda for 2023 was -190.1 M, a 45.33% increase from 2022.
- Prothena Corporation plc annual ebitda for 2022 was -130.8 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Prothena Corporation plc EBITDA — FAQ
Prothena Corporation plc (PRTA) ebitda over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PRTA's ebitda history?
The chart and table above show Prothena Corporation plc's ebitda by year and by quarter, including the growth rate.